Literature DB >> 15569328

Creatinine levels among Mexican Americans, Puerto Ricans, and Cuban Americans in the Hispanic Health and Nutrition Examination Survey.

Rudolph A Rodriguez1, German T Hernandez, Ann M O'Hare, David V Glidden, Eliseo J Pérez-Stable.   

Abstract

BACKGROUND: Although Latinos constitute the largest and fastest growing minority group in the United States, little is known about the prevalence of renal disease among different Latino subgroups.
METHODS: We used data from the Hispanic Health and Nutrition Examination Survey (HHANES) to compare serum creatinine measurements among Mexican Americans, mainland Puerto Ricans, and Cuban Americans. We compared estimated creatinine clearance across Latino subgroups adjusted for demographic, clinical, and socioeconomic characteristics (including known predictors of chronic kidney disease) using survey logistic regression analysis.
RESULTS: Cuban Americans had higher mean serum creatinine levels than the other groups across both gender and age categories. In multivariable analysis, Puerto Ricans [odds ratio (OR) 1.74, 95% confidence interval (CI) 1.16 to 2.60] and Cuban Americans (OR 4.59, CI 2.53 to 8.31) were more likely than the referent category of Mexican Americans to have an estimated creatinine clearance < 60 mL/min/1.73 m2.
CONCLUSION: Serum creatinine levels differ substantially among Latino subgroups, suggesting national origin needs to be taken into consideration in studies of renal disease in Latinos. In addition, our findings highlight the need for more contemporary studies directly comparing both incidence rates of end-stage renal disease and measured renal function among Latino subgroups, perhaps leading to subgroup-specific prediction equations.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15569328     DOI: 10.1111/j.1523-1755.2004.66025.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  6 in total

1.  CKD in Hispanics: Baseline characteristics from the CRIC (Chronic Renal Insufficiency Cohort) and Hispanic-CRIC Studies.

Authors:  Michael J Fischer; Alan S Go; Claudia M Lora; Lynn Ackerson; Janet Cohan; John W Kusek; Alejandro Mercado; Akinlolu Ojo; Ana C Ricardo; Leigh K Rosen; Kaixiang Tao; Dawei Xie; Harold I Feldman; James P Lash
Journal:  Am J Kidney Dis       Date:  2011-06-25       Impact factor: 8.860

2.  Incident Chronic Kidney Disease Risk among Hispanics/Latinos in the United States: The Hispanic Community Health Study/Study of Latinos (HCHS/SOL).

Authors:  Ana C Ricardo; Matthew Shane Loop; Franklyn Gonzalez; Claudia M Lora; Jinsong Chen; Nora Franceschini; Holly J Kramer; Stephanie M Toth-Manikowski; Gregory A Talavera; Martha Daviglus; James P Lash
Journal:  J Am Soc Nephrol       Date:  2020-04-16       Impact factor: 10.121

3.  Physical activity participation among Caribbean Hispanic women living in New York: relation to education, income, and age.

Authors:  Elsa-Grace V Giardina; Melissa Laudano; Emily Hurstak; Alan Saroff; Elaine Fleck; Robert Sciacca; Bernadette Boden-Albala; Julia Cassetta
Journal:  J Womens Health (Larchmt)       Date:  2009-02       Impact factor: 2.681

4.  Prevalence and Correlates of CKD in Hispanics/Latinos in the United States.

Authors:  Ana C Ricardo; Michael F Flessner; John H Eckfeldt; Paul W Eggers; Nora Franceschini; Alan S Go; Nathan M Gotman; Holly J Kramer; John W Kusek; Laura R Loehr; Michal L Melamed; Carmen A Peralta; Leopoldo Raij; Sylvia E Rosas; Gregory A Talavera; James P Lash
Journal:  Clin J Am Soc Nephrol       Date:  2015-09-28       Impact factor: 8.237

5.  Hypertension, poor glycemic control, and microalbuminuria in Cuban Americans with type 2 diabetes.

Authors:  Gustavo G Zarini; Joel C Exebio; Deva Gundupalli; Subrata Nath; Fatma G Huffman
Journal:  Int J Nephrol Renovasc Dis       Date:  2011-03-03

6.  Electronic problem list documentation of chronic kidney disease and quality of care.

Authors:  Lipika Samal; Jeffrey A Linder; David W Bates; Adam Wright
Journal:  BMC Nephrol       Date:  2014-05-04       Impact factor: 2.388

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.